Gadolinium Meets Medicinal Chemistry: MRI Contrast Agent Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|7|751-778

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.7, 2005-04, pp. : 751-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent

By Chen Zhijin   Yu Dexin   Liu Chunxi   Yang Xiaoyan   Zhang Na   Ma Chunhong   Song Jibin   Lu Zaijun  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 657-665

Informa Healthcare

Access to resources Recommend Favorite

The Use of Molecular Descriptors in the Design of Gadolinium (III) Chelates as MRI Contrast Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-12 ,pp. : 845-859

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry Meets Proteomics: Fractionation of the Human Plasma Proteome

By  

Current Medicinal Chemistry, Vol. 20, Iss. 4, 2013-02 ,pp. : 483-490

Bentham Science Publishers

Access to resources Recommend Favorite

Dynamic Contrast-Enhanced MRI in Oncology Drug Development

By  

Current Clinical Pharmacology, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-122

Bentham Science Publishers

Access to resources Recommend Favorite

Chemistry of Tumour Targeted T1 Based MRI Contrast Agents

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-08 ,pp. : 1158-1183

Bentham Science Publishers

Access to resources Recommend Favorite